- Home
- KZIA vs NIM Comparison
KZIA vs NIM Comparison
Compare KZIA & NIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KZIA | NIM |
|---|---|---|
| Founded | 1994 | 1992 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.8M | 114.1M |
| IPO Year | 2002 | N/A |
Fundamental Metrics
Financial Performance| Metric | KZIA | NIM |
|---|---|---|
| Price | $12.95 | $9.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $19.50 | N/A |
| AVG Volume (30 Days) | ★ 229.2K | 18.8K |
| Earning Date | 06-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.46% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.30 | $8.80 |
| 52 Week High | $17.40 | $9.94 |
Technical Indicators
Market Signals| Indicator | KZIA | NIM |
|---|---|---|
| Relative Strength Index (RSI) | 55.10 | 37.71 |
| Support Level | $5.71 | $9.02 |
| Resistance Level | $14.82 | $9.44 |
| Average True Range (ATR) | 1.03 | 0.10 |
| MACD | -0.30 | -0.01 |
| Stochastic Oscillator | 35.24 | 5.71 |
Price Performance
Historical ComparisonAbout KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
About NIM Nuveen Select Maturities Municipal Fund
Nuveen Select Maturities Municipal Fund is a diversified closed-end management investment company. Its primary investment objective is to provide current income exempt from regular federal income tax, consistent with the preservation of capital. Its secondary investment objective is to enhance portfolio value relative to the municipal bond market through investments in tax-exempt municipal obligations that are underrated or undervalued, or that represent municipal market sectors that are undervalued.